MedTrace Logo

Patient Satisfaction and Safety With Propofol Based Sedation With or Without Fentanyl for Gastrointestinal Endoscopy

NCT03803449 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2019-01-14

No results posted yet for this study

Summary

Patient satisfaction and safety with propofol based sedation with or without fentanyl for gastrointestinal endoscopy

Conditions

  • Patient Satisfaction

Interventions

DRUG

50-200mg propofol

participants in both groups are given standard regimen including 50-200mg propofol.

DRUG

50ug fentanyl

participants in fentanyl group are given intervention regimen: 50ug fentanyl.

DRUG

1 mg midazolam

participants in both groups are given standard regimen including 1 mg midazolam.

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • yanqing li, Dr. · Qilu Hospital of Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-07-30
Completion
2019-10-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803449 on ClinicalTrials.gov